Success Storys

SuccesS STORYS

INTERNATIONAL CUTTING-EDGE RESEARCH AND INNOVATIONS
from Kaiserslautern

The science and innovation region of Kaiserslautern is a hotspot for digital transformation in Germany. Not only are there a large number of renowned research institutes here, but many companies have also settled here in recent years, from major international corporations to hidden champions and SMEs to start-ups.
All of these institutions and companies are driving research and innovation in the field of digital transformation – you can find their latest success stories here:

Rupak Majumdar, Scientific Director of the Max Planck Institute for Software Systems (MPI-SWS), has secured an ERC Advanced Grant worth approximately 2.5 million euros.

Learn more

Kaiserslautern was granted city rights 750 years ago. In 2026, the city plans to celebrate this historic event in style, honoring both its long tradition and its modern transformation.

Learn more

On May 1, 2026, the European Magnetism Association (EMA) announced that the 2026 Dominique Givord Award would be presented to Prof. Dr. Burkard Hillebrands of the RPTU Kaiserslautern-Landau. The award is considered the highest European honor in the field of magnetism.

Learn more

At the Theodor Zink Museum, 46 students were honored for their entries in the 73rd European Competition. Under the theme “Your Europe: Rights, Respect—Reality?!,” approximately 75,000 young people across Germany creatively explored the topics of democracy, human rights, and social cohesion.

Learn more

The Institute for Technology and Work (ITA) is celebrating its 30th anniversary. On its anniversary page, “30 Years of ITA – Shaping the Future of Work,” the institute invites anyone interested to share their experiences and ideas.

Learn more

The Chemical Industry Fund (FCI) is providing a total of 100,000 euros to RPTU to integrate data science into the chemistry curriculum and is supporting a total of 19 universities and 4 colleges nationwide in preparing students for the digitized chemical and pharmaceutical workforce.

Learn more